Top Tweets for #pert2026
That’s a wrap on #PERT2026 in Boston!
Thank you to everyone who joined us for meaningful conversations and shared learning focused on advancing pulmonary embolism care.
We’re especially grateful to Dr. Kenneth Rosenfield (@krosenfieldMD), Dr. Sripal Bangalore (@SripalBangalore) and Dr. Maya Serhal for sharing their real-world experiences with the Symphony Thrombectomy System during our lunch symposium — and to the clinicians, partners and attendees who made this year’s meeting so impactful.
@PERTConsortium #PulmonaryEmbolism #thrombectomy
Rx only. ISI: https://t.co/HZEaDBIc8e
Thank you to our faculty, physician partners, and everyone who stopped by to make PERT 2026 such a memorable event. We look forward to continuing these important conversations and driving innovation together.
#PERT2026 #AlphaVac #CardiovascularCare
Risk: https://t.co/SHda0hVDUu
So grateful for mentors who not only lead in the field, but make space for the next generation of women to lead too. ❤️
@RosovskyRachel @FMaeWestMD
#PERT2026 #WomenLeaders @PERTConsortium
That wraps up an excellent panel on venous disease in 2026, moderated by @SGilyardMD! Up next: PERT in Action: You make the call! #PERT2026
@AnahitaDua debating the Open Vein hypothesis with the advances in endovascular techniques since the ATTRACT trial. “If I had a DVT, take it out.” #PERT2026
Live now at #PERT2026: How many “retrievable” IVC filters are actually retrieved? Are IVC filters obsolete? Dr. Maidah Yaqoob sharing how and why this dynamic persists.
Dr. Joanna Pepke-Zaba from @Cambridge_Uni starts our second session with a great talk on imaging pattern reconition in CTEPH. #PERT2026
Dr. Steven Abramowitz from @medstarvascular argues the other side: PERT coordination takes a village. #PERT2026
Dr. Samuel Horr from @TriStarHealth starts our second debate on PERT systems of care: keep PERT small. #PERT2026
@CharlesBRoss3 from @PiedmontHealth presents the other side of the debate - when you SHOULD transfer PERT patients. #PERT2026
Nothing like ending the day with cases from around the world! So exciting to hear riveting cases and discussion 🌎 #PERT2026
Dr. Sasha Wong bringing some challenging numbers to the SEARCH debate!
An estimated 172,000 CPETs annually would be needed in the U.S. if used as a first test for symptomatic post-PE patients. Can we realistically scale this approach given limited access to CPET? #PERT2026 #PERTTrainee
Dr. Gabe Fontaine takes on the challenging side of the alteplase vs. tenecteplase debate, making the case for tenecteplase in PE! With far less evidence compared with alteplase, can we justify its use? #PERT2026
The vast majority of PE thrombolysis studies have focused on alteplase, but questions remain about optimal agent and dosing.
Curious how others are using reduced-dose thrombolysis in practice. Which patients, what dose, and what factors drive your decisions? #PERT2026
Dr. Rech kicks off the long-awaited debate on alteplase vs. tenecteplase for PE! Two thrombolytics, different pharmacologic profiles, and important questions about efficacy, safety, and bleeding risk. #PERT2026
Dr. Stephan Moll raises important concerns about bleeding risk with thrombolytics in older patients.
HI-PEITHO suggests less apparent benefit and potentially greater bleeding risk in patients ≥75 years.
How should this influence our approach in adv therapies?
#PERT2026
Many PE trials excluded patients >80 years old. Can we safely extrapolate their findings to older adults?
Chronological age ≠ biological age. Individualized assessment of frailty, comorbidities, and risks and benefits remains critical in guiding PE care. #PERT2026
Dr. Anna Parks kicking off a lively debate on how age should influence clinical decision-making in PE care. How should age factor into risk stratification and treatment decisions? #PERT2026
In the Top PE Papers session, Dr. @GregoryPiazza4 presents the results of the exciting #HIPRO trial, showing that low-dose apixaban reduced the rate of recurrent VTE at 12 months in patients with provoked VTE #pert2026
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers